John C Reed Johnson & Johnson (JNJ) insider trading activity
John C Reed is EVP, Innovative Medicine, R&D of JOHNSON & JOHNSON. Currently has a direct ownership of 10,658 shares of JNJ, which is worth approximately $2.13 Million. The most recent transaction as insider was on Oct 17, 2025, when has been sold 21,721 shares (Common Stock) at a price of $192.71 per share, resulting in proceeds of $4,185,853. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
10.7K
0%
3M change
7.94%
12M change
Total Value Held
$2.13 Million
JOHN C REED Transaction History
JCR
John C Reed
EVP, Innovative Medicine, R&D
New Brunswick, NJ